EPB251 Virological failure and acquired drug resistance among ART-experienced people living with HIV in Nepal: a nationally representative surveillance studyE-posterResistance to ART
EPE053 Virological outcomes and ARV switch profiles one year after dolutegravir transition among children in southern MozambiqueE-posterImplementation science of scaling up HIV treatment
EPE397 Virtual HIV counseling: How to access MSM and transgender people in rural areas in Paraguay in the context of the COVID-19 pandemicE-posterImpact of COVID-19 on HIV testing services
EPA032 Virtual memory CD8+ T-cells exhibit highly cytotoxic profiles in people with HIV, and are expanded by N-803E-posterCellular immunity; T cell vaccines
EPD532 Virtual monitoring, evaluation and learning on HIV service accessibility during COVID 19: learnings & best practicesE-posterSocial and behavioural aspects and approaches to COVID-19
EPD001 Visual access to create greater comprehension: Incorporating the visual arts into a representational analysis of HIV community dialogue on living with HIV and a quality of lifeE-posterCommunity engagement in research and research dissemination
EPA085 Vitamin D supplementation enhances cytotoxic response in patients with severe COVID-19E-posterImmune responses to SARS-Cov2
EPE393 Voluntary Medical Male Circumcision (VMMC) service model rebranding amidst novel corona virus-19 (COVID-19) pandemic in meeting set targets in ZambiaE-posterImpact of COVID-19 on HIV prevention services
EPB047 Voriconazole or amphotericin B deoxycholate: which is the preferred induction therapy in HIV-infected patients with talaromycosis?E-posterOpportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections
EPF161 Water and food insecurity are linked with increased HIV vulnerabilities during the COVID-19 pandemic among urban refugee youth in Kampala, UgandaE-posterImpact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons
2421 - 2430 of 2485 items